Antibiotic eluting clay mineral (Laponite®) for wound healing application: an in vitro study

Journal of Materials Science: Materials in Medicine

Volumn 25, Issue 11, 2014, Pages 2513-2526

  Ghadiri, M ^a   Chrzanowski, W ^a,b   Rohanizadeh, R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Dankook University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL AGENTS; CELL CULTURE; CHEMICAL ANALYSIS; CYTOTOXICITY; FIBROBLASTS; HYDROGELS;

ANALYTICAL METHOD; ANTIBACTERIAL EFFECTS; CYTOTOXIC EFFECTS; FIBROBLAST CULTURES; PHYSICOCHEMICAL PROPERTY; WOUND DRESSING MATERIALS; WOUND HEALING APPLICATIONS; WOUND HEALING PROCESS;

ANTIBIOTICS;

ALGINIC ACID; MAFENIDE; NANOPARTICLE; ANTIINFECTIVE AGENT; DELAYED RELEASE FORMULATION; LAPONITE; SILICATE;

ANTIMICROBIAL ACTIVITY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BURN; CELL PROLIFERATION; CLAY; CLAY MINERAL; CONTROLLED STUDY; CYTOTOXICITY; DECOMPOSITION; DEGRADATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG EFFICACY; DRUG RELEASE; ESCHERICHIA COLI; FIBROBLAST CULTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; ION EXCHANGE; MINIMUM INHIBITORY CONCENTRATION; MOISTURE VAPOR TRANSMISSION RATE; NEWBORN; NONHUMAN; PHYSICAL CHEMISTRY; PSEUDOMONAS AERUGINOSA; SKIN FIBROBLAST; STAPHYLOCOCCUS AUREUS; THERMOGRAVIMETRY; WATER ABSORPTION; WOUND DRESSING; WOUND FLUID; WOUND HEALING; X RAY POWDER DIFFRACTION; ADMINISTRATION AND DOSAGE; BACTERIAL INFECTIONS; BACTERIAL PHENOMENA AND FUNCTIONS; BANDAGE; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; MATERIALS TESTING; PHYSIOLOGY; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTERIAL PHYSIOLOGICAL PHENOMENA; BANDAGES; CELL SURVIVAL; CELLS, CULTURED; DELAYED-ACTION PREPARATIONS; HUMANS; MATERIALS TESTING; SILICATES; WOUND HEALING; WOUND INFECTION;

EID: 84910152568     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-014-5272-7     Document Type: Article

References (42)

1. Connolly S (2012) in Service ASBI (ed) Agency For Clinical Innovation Australia.
2. Zhu XB, Chang XJ, Cui YM, Zou XJ, Yang D, Hu Z. Solid-phase extraction of trace Cu(II) Fe(III) and Zn(II) with silica gel modified with curcumin from biological and natural water samples by ICP-OES. Microchem J. 2007;86:189–94.
3. Moncrief JA, Lindberg RB, Switzer WE, Fruitt BA. The use of a topical sulfonamide in the control of burn wound sepsis. J Trauma Injury Infect Crit Care. 1966;6:407–19.
4. Falcone PA, Harrison HN, Sowemimo GO, Reading GP. Mafenide acetate concentrations and bacteriostasis in experimental burn wounds treated with a three-layered laminated mafenide–saline dressing. Ann Plast Surg. 1980;5:266–9.
5. Dash AK, Saha S. Analytical profiles of drug substances and excipients, vol. 24. San Diego: Academic Press; 1996. p. 277–305.
6. United States Pharmacopeia and National Formulary (USP-NF). Encyclopedia of global health. Thousand Oaks: SAGE; 2008.
7. Lee J, Marvin J, Heimbach D, Grube B. Use of 5% sulfamylon (mafenide) solution after excision and grafting of burns. J Burn Care Rehabil. 1988;9:602–5.
8. Harrison HN, Shuck JM, Caldwell E. Studies of the pain produced by mafenide acetate preparations in burns. Arch Surg. 1975;110:1446–9.
9. White MG, Asch MJ. Acid–base effects of topical mafenide acetate in the burned patient. N Engl J Med. 1971;284:1281–6.
10. McCauley RL, Li Y-Y, Poole B, et al. Differential inhibition of human basal keratinocyte growth to silver sulfadiazine and mafenide acetate. J Surg Res. 1992;52:276–85.
11. McCauley RL, Linares HA, Pelligrini V, Herndon DN, Robson MC, Heggers JP. In vitro toxicity of topical antimicrobial agents to human fibroblasts. J Surg Res. 1989;46:267–74.
12. Erdmann D, Hussmann J, Kucan JO. Treatment of a severe alkali burn. Burns. 1996;22:141–6.
13. Aguzzi C, Cerezo P, Viseras C, Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl Clay Sci. 2007;36:22–36.
14. Betty KR, Day GT. Spectrophotometric determination of boron in nuclear-grade uranium-oxides with curcumin after extraction with 2-ethylhexane-1,3-diol. Analyst. 1986;111:455–7.
15. Li Z, Chang P-H, Jiang W-T, Jean J-S, Hong H. Mechanism of methylene blue removal from water by swelling clays. Chem Eng J. 2011;168:1193–200.
16. Viseras C, Aguzzi C, Cerezo P, Lopez-Galindo A. Uses of clay minerals in semisolid health care and therapeutic products. Appl Clay Sci. 2007;36:37–50.
17. Sinha Ray S, Okamoto M. Polymer/layered silicate nanocomposites: a review from preparation to processing. Prog Polym Sci. 2003;28:1539–641.
18. Ghadiri M, Hau H, Chrzanowski W, Agus H, Rohanizadeh R. Laponite clay as a carrier for in situ delivery of tetracycline. RSC Advances. 2013;3(43):20193–201.
19. Sagert KB, United States Pharmacopeia and National Formulary (USP-NF). Encyclopedia of global health. SAGE Publications, Thousand Oaks.
20. Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis. 2009;49:1749–55.
21. Bippus L, Jaber M, Lebeau B. Laponite and hybrid surfactant/laponite particles processed as spheres by spray-drying. New J Chem. 2009;33:1116–26.
22. Wesolowski M, Kosecka E, Erecinska J, Kobylczyk K. The influence of chemical structure of sulfonamides on the course of their thermal decomposition. J Therm Anal Calorim. 2003;74:465–76.
23. Dumville JC, O’Meara S, Deshpande S, Speak K. Alginate dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev. 2013;7:CD009101.
24. Li ZH, Kolb VM, Jiang WT, Hong HL. Ftir and Xrd investigations of tetracycline intercalation in smectites. Clays Clay Miner. 2010;58:462–74.
25. Elsner JJ, Zilberman M. Antibiotic-eluting bioresorbable composite fibers for wound healing applications: microstructure, drug delivery and mechanical properties. Acta Biomater. 2009;5:2872–83.
26. Makhmalzadeh BS. Preparation and evaluation of mafenide acetate liposomal formulation as eschar delivery system. Int J Drug Dev Res. 2011;3:129–40.
27. Tamimi F, Torres J, Bettini R, et al. Doxycycline sustained release from brushite cements for the treatment of periodontal diseases. J Biomed Mater Res Part A. 2008;85A:707–14.
28. Ghadiri M, Hau H, Chrzanowski W, Agus H, Rohanizadeh R. Laponite clay as a carrier for in situ delivery of tetracycline. RSC Adv. 2013;3:20193–201.
29. Jung H, Kim H-M, Choy YB, Hwang S-J, Choy J-H. Itraconazole–Laponite: kinetics and mechanism of drug release. Appl Clay Sci. 2008;40:99–107.
30. Kumar P, Jasra RV, Bhat TSG. Evolution of porosity and surface acidity in montmorillonite clay on acid activation. Ind Eng Chem Res. 1995;34:1440–8.
31. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959–64.
32. Grzesiak JJ, Pierschbacher MD. Shifts in the concentrations of magnesium and calcium in early porcine and rat wound fluids activate the cell migratory response. J Clin Investig. 1995;95:227–33.
33. Wang C–C, Juang L-C, Lee C-K, Hsu T-C, Lee J-F, Chao H-P. Effects of exchanged surfactant cations on the pore structure and adsorption characteristics of montmorillonite. J Colloid Interface Sci. 2004;280:27–35.
34. Oh ST, Kim WR, Kim SH, Chung YC, Park JS. The preparation of polyurethane foam combined with pH-sensitive alginate/bentonite hydrogel for wound dressings. Fibers Polymers. 2011;12:159–65.
35. Sirousazar M, Kokabi M, Hassan ZM. Swelling behavior and structural characteristics of polyvinyl alcohol/montmorillonite nanocomposite hydrogels. J Appl Polym Sci. 2012;123:50–8.
36. Sirousazar M, Kokabi M, Hassan ZM, Bahramian AR. Dehydration kinetics of polyvinyl alcohol nanocomposite hydrogels containing Na-montmorillonite nanoclay. Sci Iran. 2011;18:780–4.
37. Gorrasi G, Pantani R, Murariu M, Dubois P. PLA/halloysite nanocomposite films: water vapor barrier properties and specific key characteristics. Macromol Mater Eng. 2014;299:104–15.
38. Glasser JS, Guymon CH, Mende K, Wolf SE, Hospenthal DR, Murray CK. Activity of topical antimicrobial agents against multidrug-resistant bacteria recovered from burn patients. Burns. 2010;36:1172–84.
39. Holder IAP. Wet disc testing of mafenide hydrochloride chlorhexidine gluconate, and triple antibiotic solution against bacteria isolated from burn wounds. J Burn Care Rehabil. 1990;11:301–4.
40. Hemmila MR, Mattar A, Taddonio MA, et al. Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury. Surgery. 2010;148:499–509.
41. Zreiqat H, Howlett CR, Zannettino A, et al. Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. J Biomed Mater Res. 2002;62:175–84.
42. Cooper ML, Boyce ST, Hansbrough JF, Foreman TJ, Frank DH. Cytotoxicity to cultured human keratinocytes of topical antimicrobial agents. J Surg Res. 1990;48:190–5.